Tag: <span>Regeneron antibody trial</span>

Home / Regeneron antibody trial
Researchers recruiting patients for Regeneron antibody trial
Post

Researchers recruiting patients for Regeneron antibody trial

Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center are jointly testing monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19, and are starting to recruit patients. The scientists are testing a double antibody cocktail called REGN-COV2 (REGN10933+REGN10987), which had favourable results in mouse models and a positive review of the Phase I safety evaluation in...